Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Spina bifida diagnostic study of choice

Introduction

Overview

Overview

Ultrasound is the imaging modality of choice for characterisation of the open spina bifida spinal lesions. On two and tree-dimensional ultrasound, spina bifida is characterized by: Vertebral defect, splayed vertebral pedicles and disrupted vertebrae. The ultrasound must be performed when a positive alpha-fetoprotein is detected in the triple screening test between the 15th and 20th week of pregnancy to confirm the diagnosis.

Diagnostic Study of Choice

Diagnostic Study of Choice

Study of choice

  • Ultrasound is the imaging modality of choice for characterisation of the open spina bifida spinal lesions.[1]
  • On two and tree-dimensional ultrasound, spina bifida is characterized by:[2]
Sequence of Diagnostic Studies

The ultrasound must be performed when a positive alpha-fetoprotein is detected in the triple screening test between the 15th and 20th week of pregnancy to confirm the diagnosis.[3][4][5][6]

References

References

  1. ↑ Trudell AS, Odibo AO (April 2014). “Diagnosis of spina bifida on ultrasound: always termination?”. Best Pract Res Clin Obstet Gynaecol. 28 (3): 367–77. doi:10.1016/j.bpobgyn.2013.10.006. PMID 24373566.
  2. ↑ Lee W, Chaiworapongsa T, Romero R, Williams R, McNie B, Johnson A, Treadwell M, Comstock CH (June 2002). “A diagnostic approach for the evaluation of spina bifida by three-dimensional ultrasonography”. J Ultrasound Med. 21 (6): 619–26. PMID 12054297.
  3. ↑ Péron FG, McCarthy JL, Guerra F (April 1966). “Further studies on corticosteroidogenesis. IV. Inhibition of utilization of biological substrates for corticoid synthesis by high calcium concentrations. Possible role of transhydrogenase in corticosteroidogenesis”. Biochim. Biophys. Acta. 117 (2): 450–69. PMID 4381295.
  4. ↑ Hu Z, Liu X, Li L, Jia C, Li D, Liu R (October 2014). “[Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes]”. Zhonghua Fu Chan Ke Za Zhi (in Chinese). 49 (10): 749–53. PMID 25537246.
  5. ↑ Wyshak G, Haase JV (November 1976). “Profile of dental hygienists”. Dent Hyg (Chic). 50 (11): 497–501. PMID 1071059.
  6. ↑ Shcherbukhin VV, Khramtsov AV, Zemskov VM, Filatov AV (April 1987). “[Poisson equalization of multicomponent cytofluorograms]”. Tsitologiia (in Russian). 29 (4): 497–502. PMID 3111043.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]